The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

Threats to the NCI COE agenda impede our ability to meet the needs of our cancer center catchment area communities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Community Outreach and Engagement (COE), now augmented with the Plan to Enhance Diversity (PED), is critical and central to the impact of NCI-designated cancer centers, and both are set forth as required components for the NCI Cancer Center Support Grant (CCSG). 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Kim F. Rhoads, MD, MS, MPH
Associate professor of epidemiology & biostatistics, Associate director for community engagement, Helen Diller Family Comprehensive Cancer Center, UCSF School of Medicine
Folakemi T. Odedina, PhD
Professor, Division of Hematology/Oncology, Enterprise deputy director, Community Outreach & Engagement, Mayo Clinic Comprehensive Cancer Center 
Monica L. Baskin, PhD
Professor, Division of Hematology/Oncology, The University of Pittsburgh School of Medicine; Associate director, Community Outreach and Engagement, UPMC Hillman Cancer Center 
Vanessa B. Sheppard, PhD
Professor, Theresa A. Thomas Memorial Chair in Cancer Prevention and Control, Founding interim dean, School of Population Health, Associate director, Community Outreach Engagement and Health Disparities Research, Massey Comprehensive Cancer Center, Virginia Commonwealth University
Hayley S. Thompson, PhD
Professor, Department of Oncology, Wayne State University School of Medicine; Associate center director, Community Outreach & Engagement,
Karmanos Cancer Institute
Kimlin Tam Ashing, PhD
Professor, Beckman Research Institute, Associate cancer center director, Community Outreach and Engagement, Founding director, Center of Community Engagement for Research and Education, Deputy director, Division of Health Equities, City of Hope Comprehensive Cancer Center
Charnita Zeigler-Johnson, PhD, MPH
Associate professor of cancer prevention and control, Associate director, Community Outreach and Engagement, Fox Chase Cancer Center, Temple University Health System
Table of Contents

YOU MAY BE INTERESTED IN

In Brief

UCLA researchers awarded $2.5M grant from BMS Foundation to increase lung cancer screening in underserved communities

A multidisciplinary team of experts in lung cancer screening and implementation science from the UCLA Health Jonsson Comprehensive Cancer Center, the David Geffen School of Medicine at UCLA, and the UCLA Fielding School of Public Health, was awarded a $2.5 million grant from the Bristol Myers Squibb Foundation, an independent charitable organization, to spearhead a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County. 
ClinicalTrials & Tribulations

Addressing high cancer mortality in Native Hawaiian and Pacific Islander populations
A call for equity in cancer research

After reading “Breast Cancer Mortality Continues Three-Decade Decline, but Steeper Increases for Women Under 50 & AAPI Women of All Ages,” it is evident that while overall progress is being made in the fight against cancer, concerning disparities remain—particularly within the Native Hawaiian and Pacific Islander (NHPI) communities. 
By Naoto T. Ueno
In Brief

UF Health Cancer Center rolls out mobile cancer screening vehicle

UF Health officials and supporters gathered Wednesday to unveil the UF Health Cancer Center’s Mobile Cancer Screening Connector, which will take cancer screening care to a 23-county area in North Florida. UF Health photo by Nate GuidryThe University of Florida Health Cancer Center launched a 40-foot-long mobile cancer screening bus that will expand access to cancer screenings and essential health care services, including 3D mammograms and cervical, colon, and prostate cancer screenings.
Byline
Kim F. Rhoads, MD, MS, MPH
Associate professor of epidemiology & biostatistics, Associate director for community engagement, Helen Diller Family Comprehensive Cancer Center, UCSF School of Medicine
Folakemi T. Odedina, PhD
Professor, Division of Hematology/Oncology, Enterprise deputy director, Community Outreach & Engagement, Mayo Clinic Comprehensive Cancer Center 
Monica L. Baskin, PhD
Professor, Division of Hematology/Oncology, The University of Pittsburgh School of Medicine; Associate director, Community Outreach and Engagement, UPMC Hillman Cancer Center 
Vanessa B. Sheppard, PhD
Professor, Theresa A. Thomas Memorial Chair in Cancer Prevention and Control, Founding interim dean, School of Population Health, Associate director, Community Outreach Engagement and Health Disparities Research, Massey Comprehensive Cancer Center, Virginia Commonwealth University
Hayley S. Thompson, PhD
Professor, Department of Oncology, Wayne State University School of Medicine; Associate center director, Community Outreach & Engagement,
Karmanos Cancer Institute
Kimlin Tam Ashing, PhD
Professor, Beckman Research Institute, Associate cancer center director, Community Outreach and Engagement, Founding director, Center of Community Engagement for Research and Education, Deputy director, Division of Health Equities, City of Hope Comprehensive Cancer Center
Charnita Zeigler-Johnson, PhD, MPH
Associate professor of cancer prevention and control, Associate director, Community Outreach and Engagement, Fox Chase Cancer Center, Temple University Health System
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account